PI
AGN

PEAK6 Investments’s Allergan plc AGN Stock Holding History

PEAK6 Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,000
Closed -$177K – 5046
2020
Q1 		$177K Buy
+1,000
New +$188K ﹤0.01% 2950
2019
Q3 		– Sell
-20,100
Closed -$3.37M – 4560
2019
Q2 		$3.37M Buy
+20,100
New +$2.78M 0.02% 937
2019
Q1 		– Sell
-20,000
Closed -$2.67M – 4899
2018
Q4 		$2.67M Sell
20,000
-101,100
-83% -$16.6M 0.02% 1024
2018
Q3 		$23.1M Buy
+121,100
New +$22.2M 0.1% 198

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

PEAK6 Investments's AGN Position: Q2 2020 in Review

PEAK6 Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 44,463 shares — an estimated $7.87M sold.

PEAK6 Investments first reported a position in AGN in Q4 2018 and held it in 5 quarters. The position peaked at $17.9M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • PEAK6 Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • PEAK6 Investments sold 44,463 Allergan plc shares in Q2 2020, an estimated $7.87M.
  • PEAK6 Investments first reported a position in Allergan plc in Q4 2018 and held it in 5 quarters.
  • PEAK6 Investments's Allergan plc position peaked at $17.9M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on PEAK6 Investments's 13F filing for Q2 2020, filed 14 Aug 2020.